ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 64 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $564,000 | -59.7% | 114,900 | -56.6% | 0.01% | -56.0% |
Q2 2021 | $1,399,000 | +61.9% | 264,900 | +47.2% | 0.02% | +56.2% |
Q1 2021 | $864,000 | +53.7% | 179,900 | +38.5% | 0.02% | +33.3% |
Q4 2020 | $562,000 | +9.1% | 129,900 | +3.9% | 0.01% | 0.0% |
Q3 2020 | $515,000 | +8.6% | 125,000 | -32.4% | 0.01% | +20.0% |
Q2 2020 | $474,000 | +72.4% | 185,000 | +94.7% | 0.01% | +66.7% |
Q1 2020 | $275,000 | -36.9% | 95,000 | -17.4% | 0.01% | 0.0% |
Q4 2019 | $436,000 | -25.9% | 115,000 | 0.0% | 0.01% | -25.0% |
Q3 2019 | $588,000 | -17.5% | 115,000 | 0.0% | 0.01% | -11.1% |
Q2 2019 | $713,000 | -30.8% | 115,000 | -20.7% | 0.01% | -30.8% |
Q1 2019 | $1,031,000 | – | 145,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |